Linked Life Data

2133846

Source:http://linkedlifedata.com/resource/pubmed/id/2133846

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1992-4-9
pubmed:abstractText
Clinical incentive for development of neonatal cardiac xenotransplantation is clear. Approximately 10% of babies born with congenital heart disease might benefit from transplantation therapy, but human donor resources in this age group are limited. A scientific foundation upon which to base clinical trials of neonatal cardiac xenotransplantation is presented. A single clinical case and its outcome is reviewed. What was learned from this case supports continued clinical trials in the form of xenograft "bridging" to allotransplantation. There are perhaps three potential impediments to progress in xenotransplantation. These restrictions may be broadly categorized as: (1) immunological; (2) philosophical; and (3) sociological. None of these potential "barriers" is absolute and incentive is strong to continue exploration of neonatal cardiac xenotransplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0886-0440
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
210-8
pubmed:dateRevised
2005-11-16
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Another look at cardiac xenotransplantation.
pubmed:affiliation
Department of Surgery, Loma Linda University, California.
pubmed:publicationType
Journal Article, Review